Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOVOCART 3D Plus vs Microfracture for Knee Cartilage Defects
NCT01656902Phase 3Completed
- Sponsor
- TETEC AG
- Start
- May 2013
- Primary completion
- Mar 2020
- Modality
- Cell Therapies, Device-based Delivery
- Countries
- 10
01
Overview
A Phase 3 trial of NOVOCART 3D in Articular cartilage defect of the knee, sponsored by TETEC AG. Started May 2013; status: completed.
02
Drugs
NOVOCART 3D
03
Conditions
Articular cartilage defect of the knee
Beyond the preview
Go deeper on NCT01656902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01656902.